Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma
…, P Astoul, P Baas, T Berghmans… - European …, 2010 - Eur Respiratory Soc
Malignant pleural mesothelioma (MPM) is a rare tumour but with increasing incidence and a
poor prognosis. In 2008, the European Respiratory Society/European Society of Thoracic …
poor prognosis. In 2008, the European Respiratory Society/European Society of Thoracic …
[HTML][HTML] The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis
…, B Martin, M Paesmans, T Berghmans… - British journal of …, 2005 - nature.com
The proto-oncogene RAS, coding for a 21 kDa protein (p21), is mutated in 20% of lung cancer.
However, the literature remains controversial on its prognostic significance for survival in …
However, the literature remains controversial on its prognostic significance for survival in …
[HTML][HTML] Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for …
T Berghmans, M Dusart, M Paesmans… - Journal of Thoracic …, 2008 - Elsevier
Hypothesis The 2-[ 18 F]-fluoro-2-deoxy-d-glucose positron emission tomography is an
imaging tool for assessing clinical tumor, node, metastasis in non-small cell lung cancer (NSCLC)…
imaging tool for assessing clinical tumor, node, metastasis in non-small cell lung cancer (NSCLC)…
Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study
…, SW Kim, J Chaft, DV Baz, T Berghmans… - The Lancet …, 2018 - thelancet.com
Background Immune checkpoint inhibitors are a new standard of care for patients with
advanced non-small-cell lung cancer (NSCLC) without EGFR tyrosine kinase or anaplastic …
advanced non-small-cell lung cancer (NSCLC) without EGFR tyrosine kinase or anaplastic …
Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis
E Steels, M Paesmans, T Berghmans… - European …, 2001 - Eur Respiratory Soc
The role of p53, as a prognostic factor for survival in lung cancer, is controversial and the
purpose of the present systematic review of the literature is to determine this effect. Published …
purpose of the present systematic review of the literature is to determine this effect. Published …
[HTML][HTML] Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis
…, M Paesmans, C Mascaux, T Berghmans… - British journal of …, 2004 - nature.com
Among new biological markers that could become useful prognostic factors for lung carcinoma,
Ki-67 is a nuclear protein involved in cell proliferation regulation. Some studies have …
Ki-67 is a nuclear protein involved in cell proliferation regulation. Some studies have …
[HTML][HTML] Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis
AP Meert, M Paesmans, T Berghmans, B Martin… - BMC cancer, 2001 - Springer
Purpose A systematic review of the literature was carried out to determine the role of prophylactic
cranial irradiation (PCI) in small cell lung cancer (SCLC) . Methods To be eligible, full …
cranial irradiation (PCI) in small cell lung cancer (SCLC) . Methods To be eligible, full …
A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis
C Mascaux, M Paesmans, T Berghmans, F Branle… - Lung cancer, 2000 - Elsevier
Purpose: Cisplatin (CDDP) and etoposide (VP16) are considered major standard cytotoxic
drugs for small cell lung cancer (SCLC). The present systematic review had as its objective …
drugs for small cell lung cancer (SCLC). The present systematic review had as its objective …
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma
A Scherpereel, I Opitz, T Berghmans… - European respiratory …, 2020 - Eur Respiratory Soc
The European Respiratory Society (ERS)/European Society of Thoracic Surgeons (ESTS)/European
Association for Cardio-Thoracic Surgery (EACTS)/European Society for …
Association for Cardio-Thoracic Surgery (EACTS)/European Society for …
[HTML][HTML] Primary tumor standardized uptake value measured on fluorodeoxyglucose positron emission tomography is of prognostic value for survival in non-small cell …
M Paesmans, T Berghmans, M Dusart, C Garcia… - Journal of Thoracic …, 2010 - Elsevier
Introduction Few validated prognostic factors are available for survival in patients with lung
cancer. [ 18 F]-fluoro-2-deoxy-d-glucose positron emission tomography has been shown to …
cancer. [ 18 F]-fluoro-2-deoxy-d-glucose positron emission tomography has been shown to …